medigraphic.com
ISSN 0301-696X (Print)
Órgano de difusión del Servicio de Sanidad Militar y del Colegio Nacional de Médicos Militares

2018, Number 5-6

<< Back Next >>

Rev Sanid Milit Mex 2018; 72 (5-6)

Obesity. Pandemia of the century xxI

Ceballos-Macías JJ, Pérez Negrón-Juárez R, Flores-Real JA, argas-Sánchez J, Ortega-Gutiérrez G, Madriz-Prado R, Hernández-Moreno A

Language: Spanish
References: 32
Page: 332-338
PDF size: 186.22 Kb.


ABSTRACT

Obesity represents one of the most important health problems of our times, nowadays it is considered a health challenge in developed countries, as well as in those that are developing, as they have adopted the typical eating habits of the developed world, but also because of all the associated comorbidities. Obesity is associated with a very broad spectrum of pathophysiological changes such as: volume overload, hypertension, metabolic dysregulation, neurohumoral activation and systemic inflammation. The genes involved in obesity are several and are related to different processes: in the regulation of appetite, the behaviors of food search and metabolic efficiency. Weight loss with changes in lifestyle (diet and exercise) is an adequate way to improve health in patients with risk factors associated with obesity. Although there are medical and surgical treatments to achieve weight loss, these are not chosen as first intention and are only used when the primary treatment has failed.


REFERENCES

  1. Ferry FF. Ferri consultor clínico: diagnóstico y tratamiento en medicina interna. España: Elsevier; 2000. p. 617.

  2. Wilding J. Science, medicine, and the future. Obesity treatment. BMJ. 1997; 315 (7114): 997-1000.

  3. Hernández M. Encuesta Nacional de Salud y Nutrición de Medio Camino 2016: Resultados ponderados. [Presentación] Instituto Nacional de Salud Pública. 14 de diciembre 2016.

  4. Instituto Nacional de Salud Pública. Encuesta Nacional de Salud y Nutrición de Medio Camino 2016. Informe Final de Resultados.

  5. Rocchini AP, Katch V, Kveselis D, Moorehead C, Martin M, Lampman R et al. Insulin and renal sodium retention in obese adolescents. Hypertension. 1989; 14 (4): 367-374.

  6. Must A, Jacques PF, Dallal GE, Bajema CJ, Dietz WH. Long-term morbidity and mortality of overweight adolescents. A follow-up of the Harvard Growth Study of 1922 to 1935. N Engl J Med. 1992; 327 (19): 1350-1355.

  7. Cowell JM, Warren JS, Montgomery AC. Cardiovascular risk prevalence among diverse school-age children: implications for schools. J Sch Nurs. 1999; 15 (2): 8-12.

  8. Gil A, Olza J, Gil-Campos M, Gómez-Llorente C, Aguilera CM. Is adipose tissue metabolically different at different sites? Int J Pediatr Obes. 2011; Suppl 1: 13-20.

  9. Wu J, Boström P, Sparks LM, et al. Beige adipocytes are a distinct type of thermogenic fat cell in mouse and human. Cell. 2012; 150 (2): 366-76.

  10. Sidossis L, Kajimura S. Brown and beige fat in humans: thermogenic adipocytes that control energy and glucose homeostasis. J Clin Invest. 2015; 125 (2): 478-486.

  11. Bouchard C, ed. Genetics of obesity. Boca Raton, FL: CRC Press; 1994.

  12. Whitaker RC, Wright JA, Pepe MS, Seidel KD, Dietz WH. Predicting obesity in young adulthood from childhood and parental obesity. N Engl J Med. 1997; 337 (13): 869-873.

  13. Mutch DM, Clément K. Unraveling the genetics of human obesity. PLoS Genet. 2006; 2 (12): e188

  14. Rankinen T1, Zuberi A, Chagnon YC, et al. The human obesity gene map: the 2005 update. Obesity (Silver Spring). 2006; 14 (4): 529-644.

  15. González Jiménez E. Obesity: etiologic and pathophysiological analysis. Endocrinol Nutr. 2013; 60 (1): 17-24.

  16. Clément K, Vaisse C, Lahlou N, et al. A mutation in the human leptin receptor gene causes obesity and pituitary dysfunction. Nature. 1998; 392 (6674): 398-401.

  17. Farooqi IS, Bullmore E, Keogh J, et al. Leptin regulates striatal regions and human eating behavior. Science. 2007; 317 (5843): 1355.

  18. Ferrante AW Jr. Obesity-induced inflammation: a metabolic dialogue in the language of inflammation. J Intern Med. 2007; 262 (4): 408-414.

  19. Apovian CM, Aronne LJ, Bessesen DH, McDonnell ME, Murad MH, Pagotto U et al. Pharmacological management of obesity: an Endocrine Society clinical practice guideline. J Clin Endocrinol Metab. 2015; 100 (2): 342-362.

  20. Jensen MD, Ryan DH, Apovian CM, Ard JD, Comuzzie AG, Donato KA et al. 2013 AHA/ACC/TOS guideline for the management of overweight and obesity in adults: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines and The Obesity Society. Circulation. 2014; 129 (25 Suppl 2): S102-S138.

  21. Tuomilehto J, Lindström J, Eriksson JG, Valle TT, Hämäläinen H, Ilanne-Parikka P et al. Prevention of type 2 diabetes mellitus by changes in lifestyle among subjects with impaired glucose tolerance. N Engl J Med. 2001; 344 (18): 1343-1350.

  22. Qsymia (phentermine and topiramate extended-release) [prescribing in- formation]. Mountain View, CA: Vivus Inc. http://www.qsymia.com/pdf/prescribing-information.pdf. Accessed July 2, 2014.

  23. Belviq (lorcaserin) [prescribing information]. Zofingen, Switzer- land: Arena Pharmaceuticals GmbH.

  24. Shyangdan DS, Royle P, Clar C, Sharma P, Waugh N, Snaith A. Glucagon-like peptide analogues for type 2 diabetes mellitus. Cochrane Database Syst Rev. 2011; (10): CD006423.

  25. Solís-Ayala E, Carrillo-Ocampo L, Canché-Arenas A, Cortázar-Benítez L, Cabrera-Jardines R, Rodríguez-Weber F et al. Cirugía bariátrica: resultados metabólicos y complicaciones. Med Int Mex. 2013; 29 (5): 487-494.

  26. Aasheim ET, Elshorbagy AK, Diep LM, Søvik TT, Mala T, Valdivia-Garcia M et al. Effect of bariatric surgery on sulphur amino acids and glutamate. Br J Nutr. 2011; 106 (3): 432-440.

  27. Aasheim ET, Björkman S, Søvik TT, Engström M, Hanvold SE, Mala T et al. Vitamin status after bariatric surgery: a randomized study of gastric bypass and duodenal switch. Am J Clin Nutr. 2009; 90 (1): 15-22.

  28. Demaria EJ, Winegar DA, Pate VW, Hutcher NE, Ponce J, Pories WJ. Early postoperative outcomes of metabolic surgery to treat diabetes from sites participating in the ASMBS bariatric surgery center of excellence program as reported in the Bariatric Outcomes Longitudinal Database. Ann Surg. 2010; 252 (3): 559-566; discussion 566-567.

  29. Sakhaee K, Griffith C, Pak CY. Biochemical control of bone loss and stone-forming propensity by potassium-calcium citrate after bariatric surgery. Surg Obes Relat Dis. 2012; 8 (1): 67-72.

  30. Grethen E, McClintock R, Gupta CE, Jones R, Cacucci BM, Diaz D et al. Vitamin D and hyperparathyroidism in obesity. J Clin Endocrinol Metab. 2011; 96 (5): 1320-1326.

  31. Lee WJ, Hur KY, Lakadawala M, Kasama K, Wong SK, Lee YC. Gastrointestinal metabolic surgery for the treatment of diabetic patients: a multi-institutional international study. J Gastrointest Surg. 2012; 16 (1): 45-51; discussion 51-52.

  32. Adams TD, Davidson LE, Hunt SC. Weight and metabolic outcomes 12 years after gastric bypass. N Engl J Med. 2018; 378 (1): 93-96.




2020     |     www.medigraphic.com